11/21/2013

Rosetta Genomics has agreed to allow GeneKor Medical to offer its microRNA-based cancer diagnostic services in Turkey and Romania for undisclosed terms. The agreement expands on a distribution deal struck by the companies in 2010 that covers Greece.

Related Summaries